Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Bis-Thiazole Derivatives: Synthesis and Potential Cytotoxic Activity Through Apoptosis With Molecular Docking Approaches
Kamal M. Dawood, Mohamed A. Raslan, Ashraf A. Abbas, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Environmental Fate, Ecotoxicity, and Remediation of Heterocyclic Pharmaceuticals as Emerging Contaminants: A Review of Long-Term Risks and Impacts
Oussama Baaloudj, Laura Scrano, Sabino Aurelio Bufo, et al.
Organics (2025) Vol. 6, Iss. 1, pp. 1-1
Open Access
Synthesis of novel mono- and bis-pyrazolylthiazole derivatives as anti-liver cancer agents through EGFR/HER2 target inhibition
Mostafa E. Salem, Esraa M. Mahrous, Eman A. Ragab, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 16
Synthesis of novel piperazine-based bis(thiazole)(1,3,4-thiadiazole) hybrids as anti-cancer agents through caspase-dependent apoptosis
Doaa M. Mohamed, Nabila A. Kheder, Marwa Sharaky, et al.
RSC Advances (2024) Vol. 14, Iss. 34, pp. 24992-25006
Open Access | Times Cited: 4
Synthesis of Novel Aminothiazole Derivatives as Promising Antiviral, Antioxidant and Antibacterial Candidates
Rūta Minickaitė, Birutė Grybaitė, Rita Vaickelionienė, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7688-7688
Open Access | Times Cited: 18
Synthesis of 2-amino-9H-chromeno[2,3-d]thiazol-9-ones with anti-inflammatory activity via cascade reactions of 2-amino-3 iodochromones with amines and carbon disulfide
Jiangtao Tan, Yifan He, Yu Lin, et al.
RSC Advances (2024) Vol. 14, Iss. 5, pp. 3158-3162
Open Access | Times Cited: 3
Novel bis-amide-based bis-thiazoles as Anti-colorectal Cancer Agents Through Bcl-2 Inhibition: Synthesis, In Vitro, and In Vivo studies
Kamal M. Dawood, Mohamed A. Raslan, Ashraf A. Abbas, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 3, pp. 328-345
Closed Access | Times Cited: 17
Chemical synthesis and molecular docking study of new thiazole, thiophene, and thieno[2,3-d]pyrimidine derivatives as potential antiproliferative and antimicrobial agents
Ismail M. M. Othman, Zahra M. Al-Amshany, Nada Y. Tashkandi, et al.
Journal of Molecular Structure (2022) Vol. 1270, pp. 133926-133926
Closed Access | Times Cited: 16
Design and synthesis of new bis(1,2,4-triazolo[3,4-b][1,3,4]thiadiazines) and bis((quinoxalin-2-yl)phenoxy)alkanes as anti-breast cancer agents through dual PARP-1 and EGFR targets inhibition
Fatma M. Thabet, Kamal M. Dawood, Eman A. Ragab, et al.
RSC Advances (2022) Vol. 12, Iss. 36, pp. 23644-23660
Open Access | Times Cited: 16
Synthesis of phthalazine-based derivatives as selective anti-breast cancer agents through EGFR-mediated apoptosis: in vitro and in silico studies
Sara M. Emam, Samir M. El Rayes, Ibrahim A. I. Ali, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 9
Synthesis, topology, molecular docking and dynamics studies of o -phenylenediamine derivative
T. Sankar Ganesan, N. Elangovan, Munusamy Thirumavalavan, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-20
Closed Access | Times Cited: 2
Synthesis of novel phthalazine-based derivatives with potent cytotoxicity against HCT-116 cells through apoptosis and VEGFR2 inhibition
Donia El Sayed, Samir M. El Rayes, Hamdy A.M. Soliman, et al.
RSC Advances (2024) Vol. 14, Iss. 19, pp. 13027-13043
Open Access | Times Cited: 2
Synthesis and Anti-Breast Cancer Potency of Mono- and Bis-(pyrazolyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine) Derivatives as EGFR/CDK-2 Target Inhibitors
Mostafa E. Salem, Esraa M. Mahrous, Eman A. Ragab, et al.
ACS Omega (2023) Vol. 8, Iss. 38, pp. 35359-35369
Open Access | Times Cited: 6
Synthesis of Benzalacetophenone-based Isoxazoline and Isoxazole Derivatives
Saba Farooq, Zainab Ngaini
Current Organic Chemistry (2022) Vol. 26, Iss. 7, pp. 679-692
Closed Access | Times Cited: 10
Design, synthesis, molecular modelling and antitumor evaluation of S -glucosylated rhodanines through topo II inhibition and DNA intercalation
Ahmed I. Khodair, Fatimah Mohammed Alzahrani, Mohamed K. Awad, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 5
New spiro-indeno[1,2- b ]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights
Assem Barakat, Saeed Alshahrani, Abdullah Mohammed Al‐Majid, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 4
Recent advances in isatin-thiazole hybrids as potential anticancer agents
Shobhit Srivastava, Kuldeep Singh, Sujeet Kumar Gupta, et al.
Annals of Phytomedicine An International Journal (2022) Vol. 11, Iss. 2
Open Access | Times Cited: 6
Design, synthesis and cytotoxic evaluation of novel bis-thiazole derivatives as preferential Pim1 kinase inhibitors with in vivo and in silico study
Mohammad M. Al‐Sanea, Tamer Nasr, Samir Bondock, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 2
Design, Synthesis, Computational Investigations, and Antitumor Evaluation ofN-Rhodanine Glycosides Derivatives as Potent DNA Intercalation and Topo II Inhibition against Cancer Cells
Ahmed I. Khodair, Fatimah Mohammed Alzahrani, Mohamed K. Awad, et al.
ACS Omega (2023) Vol. 8, Iss. 14, pp. 13300-13314
Open Access | Times Cited: 2
A review on advances in synthetic methodology and biological profile of spirothiazolidin‐4‐ones
Jyoti Yadav, R.P. Chaudhary
Journal of Heterocyclic Chemistry (2022) Vol. 59, Iss. 11, pp. 1839-1878
Closed Access | Times Cited: 4
2-(4-Nitrophenyl)isothiazol-3(2H)-one: A Promising Selective Agent against Hepatocellular Carcinoma Cells
Sofia Marka, Maria-Eleftheria Zografaki, Georgia Tsolomiti, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 673-673
Open Access
Annulative Coupling of β‐Ketosulfoxonium Ylides and β‐Ketothioamides: Access to Thiazolines and Thiazolidin‐4‐Ones
Rahul Kumar Saini, Satyendra Kumar Pandey
Advanced Synthesis & Catalysis (2024) Vol. 366, Iss. 19, pp. 4073-4077
Closed Access
4-Methylthiazole Triggers Apoptosis and Mitochondrial Disruption in HL-60 Cells
Neslihan Meriç, Ezgi Kar, Fatih Kar
Research Square (Research Square) (2024)
Open Access
Synthesis, Molecular Docking, and Anticancer Screening of Ester‐based Thiazole Derivatives
Mustapha Musa, Muhammadu Bello, Ernest C. Agwamba
Chemistry & Biodiversity (2024)
Closed Access
Synthesis and Cytotoxicity of Novel β-Ala-Phthalazine-Based Derivatives as VEGFR2 Inhibitors and Apoptosis-Inducers Against Liver Cancer
Sara M. Emam, Samir M. El Rayes, Ibrahim A. I. Ali, et al.
Polycyclic aromatic compounds (2024), pp. 1-22
Closed Access
Clean and Efficient Green Protocol of N,N′-Bis(2-(arylazo)-2-(aroyl)vinyl)ethane-1,2-diamines in Aqueous Medium without Catalyst: Synthesis and Photophysical Characterization
Abdulrahman M. Alazemi, Kamal M. Dawood, Hamad M. Al‐Matar, et al.
ACS Omega (2024) Vol. 9, Iss. 48, pp. 47532-47542
Open Access
Page 1 - Next Page

Scroll to top